Want to see JP:4586 full AI Analyst Report?
Medrx Co., Ltd. (4586) Financial Statements
Medrx Co., Ltd. Financial Overview
Medrx Co., Ltd.'s market cap is currently $3.29B. The company's EPS TTM is $-14.23; its P/E ratio is -3.30; Medrx Co., Ltd. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 128.08M | $ 257.92M | $ 29.53M | $ 59.48M | $ 8.35M |
| Gross Profit | $ 113.01M | $ 219.19M | $ -18.43M | $ 10.45M | $ -54.25M |
| Operating Income | $ -942.00M | $ -793.05M | $ -933.57M | $ -1.10B | $ -1.06B |
| EBITDA | $ -928.13M | $ -754.62M | $ -888.00M | $ -1.05B | $ -1.00B |
| Net Income | $ -937.37M | $ -806.76M | $ -932.90M | $ -1.11B | $ -1.06B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.75B | $ 1.98B | $ 1.72B | $ 994.02M | $ 1.70B |
| Total Assets | $ 2.16B | $ 2.27B | $ 2.05B | $ 1.40B | $ 2.11B |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ -1.75B | $ -1.98B | $ -1.72B | $ -994.02M | $ -1.70B |
| Total Liabilities | $ 108.54M | $ 107.00M | $ 127.52M | $ 185.56M | $ 153.10M |
| Stockholders' Equity | $ 2.05B | $ 2.17B | $ 1.92B | $ 1.21B | $ 1.96B |
| Cash Flow | |||||
| Free Cash Flow | $ -970.86M | $ -803.00M | $ -913.76M | $ -1.08B | $ -926.23M |
| Operating Cash Flow | $ -888.11M | $ -803.00M | $ -913.00M | $ -1.07B | $ -923.69M |
| Investing Cash Flow | $ -82.75M | $ -3.15M | $ -759.00K | $ -1.96M | $ -2.54M |
| Financing Cash Flow | $ 745.09M | $ 1.07B | $ 1.64B | $ 356.31M | $ 815.91M |
Currency in JPY